The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT01707992 · COMPLETED
Trial details
- NCT number
- NCT01707992
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-20
- Primary completion
- 2015-04-13
- Enrollment
- 2199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.